Cardinal health completes sale of cordis business to hellman & friedman

Dublin, ohio, aug. 2, 2021 /prnewswire/ -- cardinal health (nyse: cah) and hellman & friedman (h&f) announced today the completion of the previously announced sale of cardinal health's cordis business to h&f. the sale price of approximately $1 billion includes the buyer's assumption of certain liabilities and the seller's retention of certain working capital accounts.

CAH Ratings Summary

CAH Quant Ranking